Arkolith/Insider Trading/BDTX/Form 4

Ra Capital Management, L.P.

DirectorBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Jul 7, 2023
Net Buying
Open-Market Buys
$4.7M
Open-Market Sells
$0
Net Open-Market Flow
$4.7M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 5, 2023Buy(P)936K$5.00$4.7M3.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-079144) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML